Growth Metrics

Merck (MRK) Dividends payables Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.18%
Dec 31, 2025 2.69%
Sep 30, 2025 3.03%
Jun 30, 2025 3.63%
Mar 31, 2025 3.44%
Dec 31, 2024 4.99%
Sep 30, 2024 5.59%
Jun 30, 2024 5.54%
Mar 31, 2024 5.30%
Dec 31, 2023 5.36%
Sep 30, 2023 5.99%
Jun 30, 2023 6.17%
Mar 31, 2023 7.68%
Dec 31, 2022 6.56%
Sep 30, 2022 6.69%
Jun 30, 2022 6.38%
Mar 31, 2022 5.73%
Dec 31, 2021 5.62%
Sep 30, 2021 5.93%
Jun 30, 2021 6.27%
Mar 31, 2021 5.68%
Dec 31, 2020 5.48%
Sep 30, 2020 9.27%
Jun 30, 2020 8.69%
Mar 31, 2020 8.41%
Dec 31, 2019 8.85%
Sep 30, 2019 9.97%
Jun 30, 2019 9.93%
Mar 31, 2019 11.01%
Dec 31, 2018 10.45%
Sep 30, 2018 0.15%
Jun 30, 2018 0.61%
Mar 31, 2018 0.23%
Dec 31, 2017 0.30%
Sep 30, 2017 0.77%
Jun 30, 2017 0.70%
Mar 31, 2017 0.54%
Dec 31, 2016 0.53%
Sep 30, 2016 0.31%
Jun 30, 2016 -0.23%
Mar 31, 2016 0.08%
Dec 31, 2015 0.08%
Sep 30, 2015 0.00%
Jun 30, 2015 -0.61%
Mar 31, 2015 -1.58%
Dec 31, 2014 -0.98%
Sep 30, 2014 -0.08%
Jun 30, 2014 1.32%
Dec 31, 2013 -1.64%
Jun 30, 2013 -1.68%
Dec 31, 2012 4.84%
Jun 30, 2012 11.22%
Mar 31, 2012 8.84%
Dec 31, 2011 8.93%
Sep 30, 2011 -0.83%
Jun 30, 2011 -0.51%
Mar 31, 2011 -1.08%
Dec 31, 2010 -1.09%